Breaking News Instant updates and real-time market news.

CLVS

Clovis

$34.39

-2.99 (-8.00%)

13:19
11/29/16
11/29
13:19
11/29/16
13:19

Results of part 1 of Clovis ARIEL2 study published in The Lancet Oncology

The results of part 1 of the ARIEL2 study, an international, multicentre, two-part, phase 2, open-label study, were published in The Lancet Oncology. Enrolment into ARIEL2 Part 1 is complete, although an extension, Part 2, is ongoing. "In patients with BRCA mutant or BRCA wild-type and LOH high platinum-sensitive ovarian carcinomas treated with rucaparib, progression-free survival was longer than in patients with BRCA wild-type LOH low carcinomas. Our results suggest that assessment of tumour LOH can be used to identify patients with BRCA wild-type platinum-sensitive ovarian cancers who might benefit from" Clovis' rucaparib, the interpretation statement of the text states in the version published online. Reference Link

  • 29

    Nov

  • 23

    Feb

CLVS Clovis
$34.39

-2.99 (-8.00%)

10/07/16
RHCO
10/07/16
NO CHANGE
Target $50
RHCO
Buy
Clovis selloff a buying opportunity, says SunTrust
SunTrust analyst Peter Lawson views today's selloff in shares of Clovis Oncology as a buying opportunity, saying today's concern "seems like noise." The analyst has a Buy rating on the stock with a $50 price target. Clovis is down 13%, or $4.64, to $31.13 but is well off the day's lows.
10/25/16
CHDN
10/25/16
INITIATION
Target $15
CHDN
Sell
Clovis initiated with a Sell at Chardan
Chardan analyst Madhu Kumar initiated Clovis with a Sell and a $15 price target.
10/25/16
CHDN
10/25/16
INITIATION
CHDN
Sell
Clovis initiated with a Sell on rucaparib worries at Chardan
As noted earlier, Chardan analyst Madhu Kumar initiated coverage of Clovis with a Sell rating and a $15 price target. Kumar says that "the lack of efficacy" and "safety signals" of the company's rucaparib drug pose "considerable risks" ahead of its February 23, 2017 PDUFA date. The analyst says that the drug "does not appear" to have greater efficacy than existing treatments, as any advantages it shows over the standard of care are not statistically significant. He adds that the product has caused many more adverse events than approved drugs that treat ovarian cancer.
10/26/16
PIPR
10/26/16
NO CHANGE
PIPR
Neutral
Piper still uncertain on Clovis position after AstraZeneca data
AstraZeneca's (AZN) Phase III study of Lynparza in ovarian cancer "substantially improved" progression-free survival over what was seen in study 19, suggesting a profile at least similar to TESARO's (TSRO) niraparib, Piper Jaffray analyst Steven Breazzano tells investors in a research note. The new data confirm that the various PARP inhibitors are more similar than different, which bodes well for Clovis Oncology's (CLVS) own maintenance study, the analyst contends. Breazzano, however, remains the sidelines with respect to Clovis shares given the "increasingly competitive dynamic" in ovarian cancer and uncertainty in the company's position in the important maintenance setting. The analyst keeps a Neutral rating on Clovis.

TODAY'S FREE FLY STORIES

IART

Integra LifeSciences

$48.31

-0.58 (-1.19%)

17:05
09/21/17
09/21
17:05
09/21/17
17:05
Hot Stocks
Integra LifeSciences enrolls first patient in Cadence ankle system study »

Integra LifeSciences has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

TIF

Tiffany

$89.85

-0.08 (-0.09%)

, RL

Ralph Lauren

$88.48

-0.63 (-0.71%)

17:04
09/21/17
09/21
17:04
09/21/17
17:04
Hot Stocks
Tiffany names Roger Farah as Chairman of Board, effective October 2 »

Tiffany & Co. (TIF)…

TIF

Tiffany

$89.85

-0.08 (-0.09%)

RL

Ralph Lauren

$88.48

-0.63 (-0.71%)

M

Macy's

$21.16

-0.32 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

VSAR

Versartis

$21.60

-0.25 (-1.14%)

17:00
09/21/17
09/21
17:00
09/21/17
17:00
Hot Stocks
Breaking Hot Stocks news story on Versartis 

Versartis trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLS

Flowserve

$42.19

-0.19 (-0.45%)

16:57
09/21/17
09/21
16:57
09/21/17
16:57
Hot Stocks
Flowserve appoints Lee Eckert as CFO »

Flowserve has named Lee…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIG

AIG

$60.50

0.38 (0.63%)

16:57
09/21/17
09/21
16:57
09/21/17
16:57
Periodicals
Regulators weigh removing SIFI 'tag' from insurer AIG, Dow Jones says »

According to the report,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACM

Aecom

$34.94

-0.06 (-0.17%)

16:54
09/21/17
09/21
16:54
09/21/17
16:54
Hot Stocks
Aecom announces capital allocation policy and $1B stock repurchase authorization »

Aecom announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALOG

Analogic

$79.95

2.35 (3.03%)

16:49
09/21/17
09/21
16:49
09/21/17
16:49
Hot Stocks
Analogic achieves ECAC standard C2 for new cabin baggage screening solution »

Analogic announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMP

Compass Minerals

$69.50

-0.45 (-0.64%)

16:39
09/21/17
09/21
16:39
09/21/17
16:39
Earnings
Compass Minerals lowers FY17 EPS view to $2.50-$2.80 from $3.00-$3.50 »

Consensus is $3.02. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

  • 29

    Sep

MDU

MDU Resources

$26.21

-0.19 (-0.72%)

16:39
09/21/17
09/21
16:39
09/21/17
16:39
Hot Stocks
MDU Resources names Jason Vollmer CFO, Stephanie Barth CAO »

MDU Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:36
09/21/17
09/21
16:36
09/21/17
16:36
General news
Money Supply M2 Weekly Change data reported »

Week of 9/11 Money Supply…

16:36
09/21/17
09/21
16:36
09/21/17
16:36
General news
Fed Balance Sheet Level data reported »

Week of 9/20 Fed Balance…

TXN

Texas Instruments

$86.05

0.22 (0.26%)

16:35
09/21/17
09/21
16:35
09/21/17
16:35
Hot Stocks
Texas Instruments raises dividend 24%, adds to repurchase program »

Texas Instruments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSAR

Versartis

$21.60

-0.25 (-1.14%)

16:34
09/21/17
09/21
16:34
09/21/17
16:34
Hot Stocks
Versartis' somavaratan did not meet primary endpoint in Phase 3 trial »

Versartis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMC

FMC Corporation

$90.44

-1.51 (-1.64%)

, DWDP

DowDuPont

$70.32

-0.09 (-0.13%)

16:34
09/21/17
09/21
16:34
09/21/17
16:34
Hot Stocks
FMC Corporation cleared for proposed acquisition of DuPont Crop Protection unit »

FMC Corporation (FMC)…

FMC

FMC Corporation

$90.44

-1.51 (-1.64%)

DWDP

DowDuPont

$70.32

-0.09 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

MCD

McDonald's

$159.03

-0.85 (-0.53%)

16:32
09/21/17
09/21
16:32
09/21/17
16:32
Hot Stocks
McDonald's increases quarterly dividend 7% »

McDonald's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

16:30
09/21/17
09/21
16:30
09/21/17
16:30
Options
Preliminary option volume of 13.2M today »

Preliminary option volume…

TGI

Triumph Group

$27.85

-0.2 (-0.71%)

, BA

Boeing

$256.04

0.58 (0.23%)

16:27
09/21/17
09/21
16:27
09/21/17
16:27
Hot Stocks
Triumph Group signs contract extensions with Boeing for ducting, floor panels »

Triumph Group (TGI)…

TGI

Triumph Group

$27.85

-0.2 (-0.71%)

BA

Boeing

$256.04

0.58 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

YOGA

YogaWorks

$4.00

-0.04 (-0.99%)

16:25
09/21/17
09/21
16:25
09/21/17
16:25
Earnings
YogaWorks sees Q3 revenue $12.7M-$13.2M, consensus $12.9M »

For the third quarter of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

VSAR

Versartis

$21.60

-0.25 (-1.14%)

16:25
09/21/17
09/21
16:25
09/21/17
16:25
Hot Stocks
Breaking Hot Stocks news story on Versartis »

Versartis trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YOGA

YogaWorks

$4.00

-0.04 (-0.99%)

16:22
09/21/17
09/21
16:22
09/21/17
16:22
Earnings
YogaWorks reports Q2 adjusted net loss $3.1M vs. adjusted net loss $2.7M in Q216 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

CSII

Cardiovascular Systems

$27.63

0.38 (1.39%)

16:20
09/21/17
09/21
16:20
09/21/17
16:20
Initiation
Cardiovascular Systems initiated  »

Cardiovascular Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

16:20
09/21/17
09/21
16:20
09/21/17
16:20
Options
Closing CBOE SPX and VIX Index summary for September 21st »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMU

Immunomedics

$11.45

0.01 (0.09%)

16:18
09/21/17
09/21
16:18
09/21/17
16:18
Syndicate
Breaking Syndicate news story on Immunomedics »

Immunomedics files 34.8M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNVR

Univar

$28.09

-0.11 (-0.39%)

16:17
09/21/17
09/21
16:17
09/21/17
16:17
Hot Stocks
Univar acquires Tagma Brasil »

Univar's wholly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

16:17
09/21/17
09/21
16:17
09/21/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.